BiotechTube
Home/Privo Technologies/Peter Goldberg
PG

Peter Goldberg

Likely Communications/Management (based on news attribution)

Privo Technologies

Therapeutic Areas

Oncology

Privo Technologies Pipeline

DrugIndicationPhase
PRV111Oral Carcinoma in Situ / High-Grade Dysplasia (Head and Neck Squamous Cell Carcinoma)Phase 3
PRV211Intraoperative Chemotherapy for Head and Neck Squamous Cell CarcinomaPhase 1/2
PRV131Intratumoral Injectable for Oral Cavity CancerPhase 1/2